RxDoctor Payments Data

Matthew Musikanth

Infectious Disease · Los Angeles, CANPI 1578300943

Payments from drug & device makers

$2,603in general payments, 2019–2025

Across 98 payments — averaging $26.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$636
  • Merck$404
  • EMD Serono, Inc.$349
  • AstraZeneca$245
  • Bausch Health US, LLC$176
  • Amgen$173
  • plus $619 from 15 others

What the payments were for

  • Food & beverage$2,603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,603 in reported general payments places this provider in the 70th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Other infectious disease in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →